Top Stories
Private jets, wildfire relief and $23,000 internet: The 2025 oddities of biopharma executive pay
2 days ago
German biotech nets $50M to advance two depression drugs, including Spravato challenger
4 hours ago
FDA approves Merck's Welireg-Keytruda combo as adjuvant treatment for kidney cancer
2 days ago
Biopharma’s 2025 industry pay report; Parabilis sets industry record IPO; and more
2 days ago
Latest
Amgen and the FDA want two different outcomes for Tavneos. What will patients do?
2 days ago
Eli Lilly invests in startup Abridge for clinical trial recruitment
2 days ago
Enliven prices $400M offering; Jazz drug Zepzelca fails confirmatory study
2 days ago
WuXi AppTec sues Pentagon in challenge over inclusion on Chinese military list
2 days ago
GSK took advantage of ASCO dip to get discount on Nuvalent
2 days ago
Novo's M&A leader leaves for Forbion; Perrigo CEO's 'personal conduct' issues led to resignation
2 days ago
Summit withdraws $500M offering, citing 'market conditions'
3 days ago
SonoThera raises $125M for non-viral gene therapy approach
4 days ago
Ethyreal lands $101M to treat both Graves' and thyroid eye disease
4 days ago
Now at FDA’s doorstep, Beren Therapeutics tacks on $300M in new financings
4 days ago
City Therapeutics gets $99M to gather data on three RNAi medicines
6 days ago
J&J makes $1B move for Firefly Bio, Carolyn Bertozzi's twist on ADCs in KRAS field
6 days ago
Sciwind has two Western partners for its obesity drug, but is open to more
3 days ago
Kardigan's $320M IPO pitch: Three borrowed heart drugs, one proven cardio CEO
3 days ago
'Going for our own moonshot': Parabilis CEO on biotech's record IPO
4 days ago
In Focus
Can AI do scientific research? Billions are pouring in to find out
3 weeks ago
Fetal gene therapy inches closer. Will embryo editing follow?
4 weeks ago
Bristol Myers reaches a crossroads as a make-or-break year takes shape
Last month
Exclusive: UC Berkeley startup bets on jumping genes for GLP-1 gene therapy
Last month
Illumina was built on DNA. Its future could be biology’s next big wave
Last year
FDA details flexibilities for new cell and gene therapies to leverage past data
Last week
Acting FDA chief isn't interested in permanent role
Last week
Latest in Pharma
Drugmakers are turning to logistics providers as trade disruptions linger, DHL exec says
3 days ago
Neion Bio lands $23M Series A to make proteins from chicken eggs
3 days ago
Exclusive: Genentech lays off top scientist Vishva Dixit, closes infectious disease research unit in restructuring
4 days ago
Novartis and Orionis strike second molecular glue deal for $40M upfront
4 days ago
Biopharma’s golden parachutes: 12 execs who took in the biggest M&A windfalls of $35M+
4 days ago
Lilly gives hospitals deadline to comply with 340B claims data policy
Last week
FDA Channel Feed
A father built a gene therapy for his daughter. He says an FDA request is the bottleneck
5 days ago
House committee directs FDA to speed up IND sign-off process
Last week
Latest in Manufacturing
Camurus’ second CRL for acromegaly drug; Teva details workforce cuts
3 days ago
WuXi AppTec added to Pentagon's list of companies linked to Chinese military
5 days ago
Pfizer's good-enough obesity data in a crowded market may force competition on price, dosing
Last week
Germany’s health-spending plan has consequences as Lilly, Boehringer scale back
Last week
Niowave’s $75M radioisotope facility; CordenPharma to buy AmbioPharm
3 weeks ago
Conclusion
This concludes the cleaning of the specified content.